Mazanti-Andersen advised Jeito Capital on the deal. The Danish biotech company NMD Pharma A/S has raised EUR 35 million in a financing round led by new...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Mazanti-Andersen represented Ascendis Pharma A/S in the transaction. Ascendis Pharma A/S (Nasdaq: ASND) has announced the pricing of its underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Shearman & Sterling advised the underwriters in the offering. Mazanti advised Y-mAbs Therapeutics.r Y-mAbs Therapeutics, Inc. executed its 2,804,878 shares of common stock at a public offering...
You must be a Standard 1 Year member to access this content.
Accura was local counsel for Oppenheimer & Co. who was lead underwriter in connection with the ADS listing. Mazanti advised Evaxion Biotech. The Danish biotech company...
You must be a Standard 1 Year member to access this content.
